Evidence map›Paper›PMID 34620183›Full record

ArticlePediatric rheumatology online journal2021

IgA vasculitis nephritis clinical course and kidney biopsy - national study in children.

Małgorzata Mizerska-Wasiak, Agnieszka Turczyn, Karolina Cichoń-Kawa, Jadwiga Małdyk, Monika Miklaszewska, Dorota Drożdż, Beata Bieniaś, Przemysław Sikora, Magdalena Drożyńska-Duklas, Aleksandra Żurowska and 2 more

Open access · goldAbstract read
In one paragraph

Article in Pediatric rheumatology online journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Modern biomarkers in IgA vasculitis with nephritis in children.Central-European journal of immunology · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Małgorzata Mizerska-WasiakDepartment of Paediatrics and Nephrology, Medical University of Warsaw, Warsaw, Poland. wasiaczki@wp.pl.ORCID http://orcid.org/0000-0003-0063-8699
Agnieszka TurczynDepartment of Paediatrics and Nephrology, Medical University of Warsaw, Warsaw, Poland.
Karolina Cichoń-KawaDepartment of Paediatrics and Nephrology, Medical University of Warsaw, Warsaw, Poland.
Jadwiga MałdykDepartment of Pathomorphology, Medical University of Warsaw, Warsaw, Poland.
Monika MiklaszewskaDepartment of Pediatric Nephrology, Jagiellonian University, Collegium Medicum, Cracow, Poland.
Dorota DrożdżDepartment of Pediatric Nephrology, Jagiellonian University, Collegium Medicum, Cracow, Poland.
Beata BieniaśDepartment of Pediatric Nephrology, Medical University of Lublin, Lublin, Poland.
Przemysław SikoraDepartment of Pediatric Nephrology, Medical University of Lublin, Lublin, Poland.
Magdalena Drożyńska-DuklasDepartment of Paediatrics, Nephrology and Hypertension, Medical University of Gdańsk, Gdansk, Poland.
Aleksandra ŻurowskaDepartment of Paediatrics, Nephrology and Hypertension, Medical University of Gdańsk, Gdansk, Poland.
Maria SzczepańskaDepartment of Paediatrics, Medical University of Silesia, Zabrze, Poland.
Małgorzata Pańczyk-TomaszewskaDepartment of Paediatrics and Nephrology, Medical University of Warsaw, Warsaw, Poland.
Medical University of Warsaw · PLGdańsk Medical University · PLJagiellonian University · PLMedical University of Lublin · PLMedical University of Silesia · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the study was to investigate the relationship between the severity of typical clinical symptoms, severity of histopathological lesions in kidney biopsies in IgA vasculitis nephritis (IgAVN) and to propose indications for kidney biopsy in children. MATERIAL AND

methodsThis retrospective study enrolled 106 patients, included in the IgAVN registry of Polish children, diagnosed by kidney biopsy. Renal and extrarenal symptoms at onset of the disease were analyzed. Biopsy results were assessed using Oxford classifications (MEST-C). The patients were divided into 3 groups depending on the severity of proteinuria: A-nephrotic proteinuria with hematuria; B-non-nephrotic proteinuria with hematuria; C-isolated hematuria.

resultsThe first symptoms of nephropathy were observed at the 0.7 (1-128.4) months from the onset of extrarenal symptoms. Kidney biopsy was performed on 39 (6-782) days after the onset of nephropathy symptoms. MEST-C score 4 or 5 was significantly more frequent in children from group A than in groups B and C. Significantly higher mean MEST-C score was found in patients with abdominal symptoms than without. In group A: S0 and T0 we found in significantly shorter time to kidney biopsy than in S1, T1-2 p < 0.05) and in group B the significantly shorter time in T0 compare to T1-2 p < 0.05). The ROC analysis shows that S1 changes appear in kidney biopsies in group A with cut off 21 days (AUC 0,702, p = 0.004, sensitivity 0.895 specificity 0.444) T1-2 changes after 35 days (AUC 0.685, p = 0.022, sensitivity 0.750, specificity 0.615), and in goupn B T1-2 cut off is 74 days (AUC 0,738, p = 0.002, sensitivity 0.667, specificity 0.833).

conclusionsIn childhood IgAVN, the severity of changes in the urine is clearly reflected in the result of a kidney biopsy. The biopsy should be performed in patients with nephrotic proteinuria no later than 3 weeks after the onset of this symptom in order to promptly apply appropriate treatment and prevent disease progression. Accompanying abdominal symptoms predispose to higher MESTC score.

Indexed as

Population SurveillanceRegistriesAdolescentBiopsyChildChild, PreschoolDisease ProgressionFemaleFollow-Up StudiesHumansIgA VasculitisKidneyMaleNephritisPolandRetrospective StudiesClinical trialsHenoch-Schönlein purpura and other vasculitidesImmunologic subjects

Identifiers

PMID34620183
PMCPMC8495907
OpenAlexW3204704098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.